
Valerio De Stefano
Articles
-
Nov 20, 2024 |
digitalcommons.osgoode.yorku.ca | Valerio De Stefano |Mathias Wouters |De Stefano
Book ChapterVos, Marc de, et al., editors. The Cambridge Handbook of Technological Disruption in Labour and Employment Law. Cambridge University Press, 2024.
-
Nov 6, 2024 |
digitalcommons.osgoode.yorku.ca | Valerio De Stefano |Ilda Durri |Charalampos Stylogiannis |Mathias Wouters
A Research Agenda for the Gig Economy and SocietyDescription"Providing a comprehensive, interdisciplinary overview of the gig economy from both a labour and employment perspective, this Research Agenda goes beyond the question of the employment status of platform workers.
-
Oct 24, 2024 |
nature.com | Tiziano Barbui |Alessandra Carobbio |Valerio De Stefano |Alessandro Rambaldi |Ayalew Tefferi
AbstractThis viewpoint summarizes findings from analyses of large personal patient databases of myeloproliferative neoplasms (MPNs) to assess the impact of thrombosis on mortality, disease progression, and second cancers (SC). Despite advances, the current incidence of arterial and venous thrombosis remains a challenge.
-
Oct 9, 2024 |
socialeurope.eu | Nicola Countouris |Valerio De Stefano
Amazon’s office mandate exposes workplace power dynamics and the need to rethink employer control. In an abrupt move that has reignited debates about working from home, Amazon has recently ordered its white-collar employees to return to the office five days a week, abandoning any remnants of remote or hybrid work options.
-
Sep 25, 2024 |
nature.com | Maria-Victoria Mateos |Katja Weisel |Valerio De Stefano |Hartmut Goldschmidt |Laure Vincent |Aurore Perrot | +2 more
AbstractTreatment of relapsed/refractory multiple myeloma (RRMM) is challenging as patients exhaust all available therapies and the disease becomes refractory to standard drug classes. Here we report the final results of LocoMMotion, the first prospective study of real-world clinical practice (RWCP) in triple-class exposed (TCE) patients with RRMM, with a median follow-up of 26.4 months (range, 0.1–35.0). Patients (N = 248) had received median 4 prior LOT (range, 2–13) at enrollment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →